{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T09:13:31Z","timestamp":1782897211267,"version":"3.54.5"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100017510","name":"UK Dementia Research Institute","doi-asserted-by":"publisher","award":["UKDRI-Edin005"],"award-info":[{"award-number":["UKDRI-Edin005"]}],"id":[{"id":"10.13039\/501100017510","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Race Against Dementia","award":["RADF-2019a-001"],"award-info":[{"award-number":["RADF-2019a-001"]}]},{"DOI":"10.13039\/100014645","name":"James Dyson Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014645","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000320","name":"Alzheimer's Society","doi-asserted-by":"publisher","award":["AS-PG-21-006"],"award-info":[{"award-number":["AS-PG-21-006"]}],"id":[{"id":"10.13039\/501100000320","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"DOI":"10.1007\/s00401-025-02966-4","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T05:27:45Z","timestamp":1765430865000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Confirmation of p-tau Ser356\u2019s association with Alzheimer\u2019s disease pathology and lowering in response to WZ4003 treatment in brain slice cultures. Reply to: \u201cPhospho-tau Ser356 is mostly confined to pre-NFT neurons in Alzheimer\u2019s pathology\u201d"],"prefix":"10.1007","volume":"150","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-6014-3734","authenticated-orcid":false,"given":"Lewis W.","family":"Taylor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7043-1450","authenticated-orcid":false,"given":"Elizabeth M.","family":"Simzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1612-1555","authenticated-orcid":false,"given":"Lauren F. P.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3903-6361","authenticated-orcid":false,"given":"Kristj\u00e1n","family":"Holt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2530-0598","authenticated-orcid":false,"given":"Tara L.","family":"Spires-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7552-7358","authenticated-orcid":false,"given":"Claire S.","family":"Durrant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"key":"2966_CR1","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1001\/jamaneurol.2023.5319","volume":"81","author":"NJ Ashton","year":"2024","unstructured":"Ashton NJ, Brum WS, Di Molfetta G, Benedet AL, Arslan B, Jonaitis E et al (2024) Diagnostic accuracy of a plasma phosphorylated tau 217 immunoassay for Alzheimer disease pathology. JAMA Neurol 81:255\u2013263. https:\/\/doi.org\/10.1001\/jamaneurol.2023.5319","journal-title":"JAMA Neurol"},{"key":"2966_CR2","doi-asserted-by":"publisher","first-page":"6912","DOI":"10.1039\/D5OB00885A","volume":"23","author":"SG Bressler","year":"2025","unstructured":"Bressler SG, Grunhaus D, Aviram A, R\u00fcdiger SGD, Hurevich M, Friedler A (2025) Specific phosphorylation patterns control the interplay between aggregation and condensation of Tau-R4 peptides. Org Biomol Chem 23:6912\u20136923. https:\/\/doi.org\/10.1039\/D5OB00885A","journal-title":"Org Biomol Chem"},{"key":"2966_CR3","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s00401-021-02264-9","volume":"141","author":"CL Croft","year":"2021","unstructured":"Croft CL, Goodwin MS, Ryu DH, Lessard CB, Tejeda G, Marrero M et al (2021) Photodynamic studies reveal rapid formation and appreciable turnover of tau inclusions. Acta Neuropathol 141:359\u2013381. https:\/\/doi.org\/10.1007\/s00401-021-02264-9","journal-title":"Acta Neuropathol"},{"key":"2966_CR4","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.1002\/anie.201913001","volume":"59","author":"M Haj-Yahya","year":"2020","unstructured":"Haj-Yahya M, Gopinath P, Rajasekhar K, Mirbaha H, Diamond MI, Lashuel HA (2020) Site-specific hyperphosphorylation inhibits, rather than promotes, tau fibrillization, seeding capacity, and its microtubule binding. Angew Chem Int Ed Engl 59:4059\u20134067. https:\/\/doi.org\/10.1002\/anie.201913001","journal-title":"Angew Chem Int Ed Engl"},{"key":"2966_CR5","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/s41591-024-03400-0","volume":"31","author":"T Islam","year":"2025","unstructured":"Islam T, Hill E, Abrahamson EE, Servaes S, Smirnov DS, Zeng X et al (2025) Phospho-tau serine-262 and serine-356 as biomarkers of pre-tangle soluble tau assemblies in Alzheimer\u2019s disease. Nat Med 31:574\u2013588. https:\/\/doi.org\/10.1038\/s41591-024-03400-0","journal-title":"Nat Med"},{"key":"2966_CR6","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1093\/brain\/awac333","volume":"146","author":"S Janelidze","year":"2022","unstructured":"Janelidze S, Bali D, Ashton NJ, Barth\u00e9lemy NR, Vanbrabant J, Stoops E et al (2022) Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer\u2019s disease. Brain 146:1592\u20131601. https:\/\/doi.org\/10.1093\/brain\/awac333","journal-title":"Brain"},{"key":"2966_CR7","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.neuron.2016.09.022","volume":"92","author":"CA Lasagna-Reeves","year":"2016","unstructured":"Lasagna-Reeves CA, de Haro M, Hao S, Park J, Rousseaux MWC, Al-Ramahi I et al (2016) Reduction of Nuak1 decreases tau and reverses phenotypes in a tauopathy mouse model. Neuron 92:407\u2013418. https:\/\/doi.org\/10.1016\/j.neuron.2016.09.022","journal-title":"Neuron"},{"key":"2966_CR8","doi-asserted-by":"publisher","unstructured":"Le LTHL, Lee G, Shin JW, Shim Y-M, Kim S-I, Park S-H, Won J-K, Lee MJ (2025) Phospho-tau Ser356 is mostly confined to pre-NFT neurons in Alzheimer\u2019s pathology. Acta Neuropathol https:\/\/doi.org\/10.1007\/s00401-025-02967-3","DOI":"10.1007\/s00401-025-02967-3"},{"key":"2966_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00401-023-02667-w","volume":"147","author":"LW Taylor","year":"2024","unstructured":"Taylor LW, Simzer EM, Pimblett C, Lacey-Solymar OTT, McGeachan RI, Meftah S et al (2024) P-tau Ser356 is associated with Alzheimer\u2019s disease pathology and is lowered in brain slice cultures using the NUAK inhibitor WZ4003. Acta Neuropathol 147:7. https:\/\/doi.org\/10.1007\/s00401-023-02667-w","journal-title":"Acta Neuropathol"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-025-02966-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00401-025-02966-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-025-02966-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T05:27:47Z","timestamp":1765430867000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00401-025-02966-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":9,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2966"],"URL":"https:\/\/doi.org\/10.1007\/s00401-025-02966-4","relation":{},"ISSN":["1432-0533"],"issn-type":[{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,11]]},"assertion":[{"value":"19 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Claire Durrant has no direct conflicts of interest with this study but receives funding from ONO Pharmaceuticals for a separate project. Tara Spires-Jones has no direct conflicts of interest with this study but has received payments for consulting, scientific talks, or collaborative research over the past 10\u00a0years from AbbVie, Sanofi, Merck, Scottish Brain Sciences, Jay Therapeutics, Cognition Therapeutics, ONO Pharmaceuticals, and Eisai. She is also a charity trustee for the British Neuroscience Association and the Guarantors of Brain and serves as a scientific advisor to several charities and non-profit institutions. The remaining authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"63"}}